Sequent Scientific Share Price

Sequent Scien.

CMP as on 27-Nov-20 9:19

₹ 154.80
1.55 1.01%

Open

₹ 154.20

Turnover (lac)

₹ 26

Prev. Close

₹ 153.25

Day's Vol (shares)

₹ 16,989

Day's Range (₹)

₹ 153.80
₹ 155.30

CMP as on27-Nov-20 9:17

₹ 154.80
1.6 1.04%

Open

₹ 156.80

Turnover (lac)

₹ 3

Prev. Close

₹ 153.20

Day's Vol (shares)

₹ 210

Day's Range

₹ 154.00
₹ 156.80

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 30-Oct-2020 - -
SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2020 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2020 as required under Regulation 33 of the Listing Regulations. Further, in continuation of our intimation dated September 28, 2020 and pursuant to Companys Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in the securities of the Company is closed from October 1, 2020 to November 8, 2020 (both days inclusive). Pursuant to Regulation 30 and Regulation 33 of the SEBI (LODR) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2020. In this regard, kindly find enclosed the following: 1. Unaudited Consolidated Financial Results along with Independent Auditors Review Report issued by the Statutory Auditors of the Company for the quarter and half year ended September 30, 2020. 2. Unaudited Standalone Financial Results along with Independent Auditors Review Report issued by the Statutory Auditors of the Company for the quarter and half year ended September 30, 2020. 3. A copy of Press Release and Investors Presentation on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2020. The Board Meeting commenced at 12:30 P.M. and concluded at 02:35 P.M. Pursuant to Regulation 30 (read with Part A of Schedule III) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, has approved the appointment of Mr. Gregory John Andrews (DIN: 08904518) as an Additional Director (Non-Executive Non-Independent) of the Company w.e.f. November 6, 2020 to hold office as such until the conclusion of ensuing Annual General Meeting of the Company. Mr. Gregory John Andrews has been nominated by CA Harbor Investments (Part of The Carlyle Group) as their nominee on the Board of the Company. Brief profile and other Information of Mr. Gregory John Andrews pursuant to SEBI Circular bearing reference CIR/CFD/CMD/4/2015 dated September 9, 2015 is given in the enclosed as an Annexure A. We request you to take the above on record. (As per BSE Announcement Dated on 06/11/2020)
Board Meeting - 17-Aug-2020 - -
Pursuant to Regulation 30 (read with Part A of Schedule III) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors held today have, inter-alia, noted the following: a) That the first tranche of the above transaction consummated on August 17, 2020 with the Sellers transferring 25.20% of the paid-up equity share capital of the Company to the Acquirer as per letter attached. b) Consequent to the above transfer, CA Harbor Investments (part of The Carlyle Group) has acquired control over the Company and has become a Promoter of the Company w.e.f. August 17, 2020. We request you to take the above on record. Pursuant to Regulation 30 (read with Part A of Schedule III) of the SEBI (LODR) Regulations, 2015, we would like to inform you that the Board of Directors of the Company at its Meeting today have, inter-alia, approved the following change in Directorship of the Company: 1. Appointment of Mr. Neeraj Bharadwaj (DIN: 01314963) and Mr. Rahul Mukim (DIN: 06996915) as Additional (Non-Executive and Non-Independent) Directors of the Company with effect from August 17, 2020 to hold office till the conclusion of ensuing Annual General Meeting of the Company. Mr. Neeraj Bharadwaj and Mr. Rahul Mukim have been nominated by CA Harbor Investments (Part of The Carlyle Group) as their nominee on the Board of the Company. 2. Resignation of Mr. KEC Rajakumar (DIN: 00044539) and Dr. S. Devendra (DIN: 00050440), Non-Executive Directors of the Company with effect from August 17, 2020. We wish to take the above on record. (AS Per BSE Announcement Dated on 17.08.2020)
Board Meeting - 27-Jul-2020 - -
SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2020 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (hereinafter referred to as the Listing Regulations), we wish to inform the Exchanges that a Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, July 30, 2020, inter-alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended June 30, 2020 as required under Regulation 33 of the Listing Regulations. Further, in continuation of our intimation dated June 29, 2020 and pursuant to Companys Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in the securities of the Company is closed from July 1, 2020 to August 1, 2020 (both days inclusive). Pursuant to Regulation 30 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Unaudited Consolidated and Standalone Financial Results for the quarter ended June 30, 2020. In this regard, kindly find enclosed the following: 1. Unaudited Consolidated Financial Results along with Independent Auditors Review Report issued by the Statutory Auditors of the Company for the quarter ended June 30, 2020. 2. Unaudited Standalone Financial Results along with Independent Auditors Review Report issued by the Statutory Auditors of the Company for the quarter ended June 30, 2020. 3. A copy of Press Release and Investors Presentation on Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2020. The Board Meeting commenced at 11:00 a.m. and concluded at 1:10 p.m. (As Per BSE Announcement Dated on 3.07.2020)
Board Meeting - 09-May-2020 - -
SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2020 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2020 as required under Regulation 33 of the Listing Regulations. Further, in continuation of our intimation dated March 26, 2020 and pursuant to Companys Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in the securities of the Company is closed from April 1, 2020 to May 14, 2020 (both days inclusive). Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter alia, considered and approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2020. In this regard, kindly find enclosed the following: 1. Audited Standalone and Consolidated Financial Results along with Independent Auditors Report issued by the Statutory Auditors of the Company for the quarter and year ended March 31, 2020. 2. A Statement on Impact of Audit Qualifications. 3. A copy of Press Release and Investors Presentation on Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2020. The Board Meeting commenced at 11:00 a.m. and concluded at 2:50 p.m. (As Per BSE Announcement dated on 12.05.2020)
Board Meeting - 08-May-2020 - -
We wish to inform you that some Promoters (detailed in the Annexure below) (collectively referred to as the Sellers) of SeQuent Scientific Limited (SeQuent) propose to sell their entire Shareholding in SeQuent to CA Harbor Investments, which belongs to the group of entities doing business globally as, The Carlyle Group, (the Acquirer) who also intends to acquire control over SeQuent, the foregoing proposed transaction being hereinafter referred to as the Proposed Transaction. The Board of Directors at their Meeting held today noted and approved the execution, delivery, and performance of the Representations and Warranties Agreement (RWA) to be entered into among the Sellers, the Acquirer, and SeQuent. The Proposed Transaction shall attract an obligation on the Acquirer to make an open offer as required under Regulations 3(1) and 4 of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 (SEBI SAST).
Board Meeting - 16-Jan-2020 - -
SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2020 ,inter alia, to consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2019 as required under Regulation 33(3)(a) of the Listing Regulations. Further, in continuation of our intimation dated December 28, 2019 and pursuant to Companys Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in the securities of the Company is closed from January 1, 2020 to January 30, 2020 (both days inclusive). Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter alia, considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2019. In this regard, kindly find enclosed the following: 1. A copy of Unaudited Standalone and Consolidated Financial Results along with Limited Review Report issued by the Statutory Auditors of the Company for the quarter and nine months ended December 31, 2019. 2. A copy of Press Release and Investors Presentation on Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2019. The Board Meeting commenced at 11:15 A.M. and concluded at 1:00 P.M. (As Per BSE Announcement Dated on 28.01.2020)